Mechanisms of Cardiovascular Disease and Toxicity

Case Study Overview

Cardiovascular toxicities (CV) are adverse drug reactions (ADRs) that affect the heart and vascular system. These toxicities present as high blood pressure, cardiac arrhythmias, heart attacks and strokes. Cardiovascular system toxicities result from injury to heart tissue, damage to blood vessels or disruption to the coagulation system. Because of diverse mechanisms, predicting drug-induced CV toxicity has remained elusive.

Human cell-based assays have been developed to screen drugs and chemicals for their potential to be toxic to the heart or circulatory system. To fully capture CV toxicity hazard, integration of results from multiple assays that detect different mechanisms will be required. Assays that may be useful include those that assess mechanisms associated with thrombosis-related side effects, vascular toxicity relevant to atherosclerosis and cardiomyocyte health and function.

We are working on standardized methods for integrating results from diverse assays and display through interactive visualizations. Such tools will help researchers learn how best to apply these platforms and incorporate results into decision-making.

See our case study on kinase inhibitors tested in phenotypic assays for different cardiovascular toxicity mechanisms: Diverse Mechanisms of Cardiovascular Toxicity.

Details

Topics: Cardiovascular DiseaseCardiovascular Toxicity
Published: September 23, 2020
Author: Alto Predict

More Information

We’ve compiled this case study’s data in a Tableau dashboard, which you can explore below. You can also read other blog posts we’ve written related to this topic.

Tableau Dashboard

Explore the Data

Related Content

A recent paper from NTP showcases the application of mechanism-based NAMs for prediction of cardiotoxic…

Is coronavirus morbidity exacerbated by environmental pollution?  A potential mechanism underlying thrombosis-related side effects connects…

Many drugs can cause adverse effects on the cardiovascular system. Oncology drugs including targeted kinase…